The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample.
Journal of psychopharmacology (Oxford, England) August 1, 2014 Will Lawn, Monica J Barratt, Martin L Williams et al.
NBOMe compounds are a new series of potent hallucinogenic drugs that activate the 5-HT2A receptor. An anonymous online survey in 2012 with 22,289 respondents found that 2.6% (582 people) had ever tried one of three NBOMe drugs, with 25I-NBOMe being the most popular at 2.0% (442 people). Nearly all (93.5%) who last tried a NBOMe drug did so in 2012, and 81.2% administered it orally or sublingually. Subjective effects resembled other serotonergic hallucinogens, but users reported higher negative effects while high and greater value for money. The most common source (41.7%) was a website. NBOMe drugs are recently emerged, often bought online, and may pose larger risks due to limited knowledge, low price, and internet availability.